02159nas a2200265 4500000000100000008004100001260004400042653001900086653002400105653001300129653002700142653001800169653001100187100001700198700002500215700001600240700001600256700001200272700001400284700001300298245007200311490000700383520147800390022002501868 2025 d bSpringer Science and Business Media LLC10aSporotrichosis10aChromoblastomycosis10aMycetoma10aParacoccidioidomycosis10aMental Health10aStigma1 aCavanaugh AM1 aRibeiro dos Santos A1 aFreitas DFS1 aVenturini J1 aFahal A1 aAzevedo C1 aGold JAW00aQuality of Life, Disability, and Fungal Neglected Tropical Diseases0 v193 a
Purpose of review: This review summarizes current literature about the disability burden of the fungal neglected tropical diseases (NTDs) sporotrichosis, chromoblastomycosis, eumycetoma, and paracoccidioidomycosis. The review highlights current knowledge gaps in global settings and describes available tools that could be adopted to fill these gaps.
Recent findings: Sporotrichosis, chromoblastomycosis, and eumycetoma often present initially as skin lesions that can become progressively disfiguring, lead to stigmatization, and cause various sequalae affecting health and function. Chronic paracoccidioidomycosis can have systemic involvement and commonly results in impaired pulmonary function, which can limit activities of daily living and employment capacity. Use of standardized tools to quantify disability with fungal NTDs has been limited to date. Standardized tools to measure the impacts on quality of life and mental health are available and have been used for similar patient populations, including persons with other fungal diseases and persons with non-fungal skin NTDs.
Summary: Fungal NTDs can be disabling. Improved understanding of the quality of life and mental health consequences might lead to greater awareness of the burden of fungal NTDs and enhance health planning to address the health and rehabilitation needs of persons affected by these diseases.
a1936-3761, 1936-377X